Pennant Investors’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,736
Closed -$686K 30
2024
Q2
$686K Hold
30,736
0.18% 19
2024
Q1
$1.81M Hold
30,736
0.45% 11
2023
Q4
$681K Buy
+30,736
New +$681K 0.15% 11